A study for a 31 year old woman who takes Adderall 20 - from FDA reports


Summary

2,572 females aged 31 (±5) who take the same drug are studied. This is a personalized study for a 31 year old female patient who has Attention Deficit Disorder With Hyperactivity. The study is created by eHealthMe based on reports from FDA.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>


On Nov, 15, 2017

2,572 females aged 31 (±5) who take Adderall 20 are studied.


Number of reports submitted per year:

Adderall 20 for a 31-year old woman.

Information of the patient in this study:

  • Age: 31
  • Gender: female
  • Conditions: Attention Deficit Disorder With Hyperactivity
  • Drugs taken:
    • Adderall 20 (amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate)

eHealthMe real world results:

Comparison with this patient's adverse outcomes:

  • Excessive Eye Blinking: 0 (0% of females aged 31 (±5) who take the drug)

As an adverse outcome could be a symptom of a condition, additional studies are listed to help identify the cause: for example, regardless of which drug is taken, how many female HBP patients aged 50 (±5) have nausea

As an adverse outcome could be a side effect of a drug, additional studies are listed to help identify the cause: for example, how many female Aspirin users aged 50 (±5) have nausea

Most common side effects over time

< 1 month:
  • drug ineffective
  • headache
  • stress and anxiety
  • fatigue
  • nausea
  • disturbance in attention
  • dizziness
  • drowsiness
  • feeling abnormal
  • irritability
1 - 6 months:
  • drug ineffective
  • fatigue
  • headache
  • stress and anxiety
  • nausea
  • migraine
  • disturbance in attention
  • drug effect decreased
  • insomnia
  • dizziness
6 - 12 months:
  • high blood pressure
  • drug ineffective
  • heart rate increased
  • stress and anxiety
  • weight decreased
  • hair loss
  • nausea
  • drug exposure during pregnancy
  • drug effect decreased
  • speech impairment (adult)
1 - 2 years:
  • gallbladder injury
  • weight decreased
  • bipolar disorder
  • drug ineffective
  • mania
  • pain
  • psychotic disorder
  • nausea
  • hypoaesthesia
  • appetite - decreased
2 - 5 years:
  • stress and anxiety
  • pain
  • fatigue
  • nausea
  • memory loss
  • malaise
  • confusional state
  • mood swings
  • suicide attempt
  • dizziness
5 - 10 years:
  • pain
  • dizziness
  • malaise
  • nausea
  • gallbladder disorder
  • procedural complication
  • stress and anxiety
  • injury
  • perforation bile duct
  • hypoaesthesia
10+ years:
  • pain
  • stress and anxiety
  • injury
  • sleep apnea syndrome
  • genital haemorrhage
  • dysmenorrhea
  • pelvic pain
  • fear
  • abdominal distension
  • uterine perforation
not specified:
  • nausea
  • fatigue
  • headache
  • stress and anxiety
  • drug ineffective
  • dizziness
  • feeling abnormal
  • pain
  • drowsiness
  • insomnia

Top conditions involved for these people *:

  • Cataplexy (321 people, 12.48%)
  • Birth Control (267 people, 10.38%)
  • Stress And Anxiety (206 people, 8.01%)
  • Multiple Sclerosis (175 people, 6.80%)
  • Drowsiness (108 people, 4.20%)

Top co-used drugs for these people *:

  • Xyrem (720 people, 27.99%)
  • Xanax (212 people, 8.24%)
  • Cymbalta (198 people, 7.70%)
  • Klonopin (149 people, 5.79%)
  • Lamictal (134 people, 5.21%)

* Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Subscribe to the study: get notified of updates to the study.

Want to find out more about the FDA reports used in the study? You can request them from FDA.

You can also:

Expand the study to include reports from both FDA and eHealthMe

Expand this study to include FDA and eHealthMe reports

What are the drugs?

  • Adderall 20 has active ingredients of amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate. It is often used in attention deficit hyperactivity disorder. (latest outcomes from Adderall 20 2,475 users)

What are the conditions?

What are the symtoms?

Could your drugs cause:

Could your conditions cause:

Related studies:

Can you answer these questions?

More questions for: Attention deficit disorder with hyperactivity, Adderall 20, Excessive eye blinking

You may be interested in these reviews

More reviews for: Attention deficit disorder with hyperactivity, Adderall 20, Excessive eye blinking